• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

CBER - Office of Compliance and Biologics Quality - Organization - Text version

The following header reflects the organizational hierarchy.

 

FOOD AND DRUG ADMINISTRATION

OFFICE OF MEDICAL PRODUCTS AND TOBACCO

CENTER FOR BIOLOGICS EVALUATION AND RESEARCH

OFFICE OF COMPLIANCE AND BIOLOGICS QUALITY

 

The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.

 

Main tel:              301-827-6190

Fax:                    301-827-3381

Address:             RKW2 Bldg Suite 1039

5515 Security Lane

Rockville, MD 20852

 

The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Biologics Evaluation and Research, Office of Compliance and Biologics Quality organization structure depicting all the organizational structures reporting to the Office Director.  These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).

 

Each organizational component will be depicted in the following standard format:

 

Title of organization.

Position title of the manager.

Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.

Standard Administrative code.

 

DIRECTOR

Mary Anne Malarkey

 

Reports directly to the Office Director

DEPUTY DIRECTOR

Mark Schwartz, J.D.

 

ASSOCIATE DIRECTOR FOR POLICY

Anita F. Richardson

 

ASSOCIATE DIRECTOR FOR REGULATORY POLICY

Diane Alexander

 

ASSOCIATE DIRECTOR FOR MANUFACTURING SCIENCE

Edward Patten, M.S.

 

ASSOCIATE DIRECTOR FOR SAFETY AND COMMUNICATION

Jean Makie

 

ASSOCIATE DIRECTOR FOR BIOINFORMATICS

Sujay Pandey, Ph.D.

(DKKBC)

 

Approved by the FDA Reorganization Coordinator and Principal Delegation Control Officer

-
-